James Andrea S.
Insider CIK 2027010 · OCX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnost | M Exercise deriv | 2026-03-26 | 2026-03-30 | 28,302 | — | $0 | 84,905 | SEC↗ |
| IMDX Insight Molecular Diagnost | F Tax w/h | 2026-03-26 | 2026-03-30 | 11,298 | $4.11 | $46.4K | 206,060 | SEC↗ |
| IMDX Insight Molecular Diagnost | M Exercise | 2026-03-26 | 2026-03-30 | 28,302 | — | $0 | 217,358 | SEC↗ |
| IMDX Insight Molecular Diagnost | D To issuer deriv | 2025-10-31 | 2025-11-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMDX Insight Molecular Diagnost | M Exercise deriv | 2025-10-31 | 2025-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMDX Insight Molecular Diagnost | M Exercise | 2025-10-31 | 2025-11-04 | 50,000 | — | $0 | 201,231 | SEC↗ |
| IMDX Insight Molecular Diagnost | M Exercise | 2025-10-31 | 2025-11-13 | 50,000 | — | $0 | 201,231 | SEC↗ |
| IMDX Insight Molecular Diagnost | F Tax w/h | 2025-10-31 | 2025-11-13 | 12,175 | $6.01 | $73.2K | 189,056 | SEC↗ |
| IMDX Insight Molecular Diagnost | A Award deriv | 2025-09-28 | 2025-09-30 | 235,000 | — | $0 | 235,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2025-03-26 | 2025-03-28 | 113,207 | — | $0 | 113,207 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2025-02-07 | 2025-02-11 | 97,561 | $2.05 | $200.0K | 151,231 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2024-12-05 | 2024-12-09 | 20,000 | $2.29 | $45.8K | 53,670 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-10-11 | 2024-10-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-10-11 | 2024-10-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2024-10-02 | 2024-10-04 | 33,670 | $2.97 | $100.0K | 33,670 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-06-20 | 2024-06-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-06-20 | 2024-06-24 | 100,000 | — | $0 | 300,000 | SEC↗ |